BrainScope® is a point of care decision support tool used to objectively assess mild head injured patients in 20 minutes or less. BrainScope is in a category of one, pioneering a breakthrough technology for mild head injury triage. It is the only FDA cleared technology to assess both likelihood of intracranial hemorrhage and concussion.
The technology uses brain electrical biomarkers to aid Clinicians in ruling out the need for a CT scan, as well as determining the likelihood of brain function impairment, such as concussion. It has been highly clinically validated with 10+ years of development, 8 research contracts funded by DOD, and 33 peer-reviewed publications.
When integrated into clinical decision making, experience has demonstrated up to a 60% reduction in unnecessary CT utilization and 40% improvement in patient length of stay. Learn more, visit BrainScope’s booth.